Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003015851 | SCV003310697 | uncertain significance | Birt-Hogg-Dube syndrome | 2022-02-02 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 528 of the FLCN protein (p.Pro528Ser). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with FLCN-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV003308420 | SCV004004241 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-05-27 | criteria provided, single submitter | clinical testing | The p.P528S variant (also known as c.1582C>T), located in coding exon 11 of the FLCN gene, results from a C to T substitution at nucleotide position 1582. The proline at codon 528 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |